Prominent role of platelets in the formation of circulating neutrophil-red cell heterocellular aggregates in sickle cell anemia

Haematologica

Volumn 99, Issue 11, 2014, Pages e214-e217

  Dominical, Venina M ^a   Samse, Leigh ^b   Nichols, James S ^b   Costa, Fernando F ^a   McCoy, J Phillip ^b   Conran, Nicola ^a   Kato, Gregory J ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Circulating neutrophil red cell heterocellular aggregates; Platelets; Sickle cell anemia

Indexed keywords

ALPHA4 INTEGRIN; CD11B ANTIGEN; CD66 ANTIGEN; HEMOGLOBIN F; HEMOGLOBIN S; INTERCELLULAR ADHESION MOLECULE 4; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG; ANTISICKLING AGENT; CELL ADHESION MOLECULE; HYDROXYUREA;

BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; FLOW CYTOMETRY; HUMAN; LETTER; LEUKOCYTE COUNT; NEUTROPHIL; PROTEIN MODIFICATION; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; THROMBOCYTE FUNCTION; ANEMIA, SICKLE CELL; CELL ADHESION; ERYTHROCYTE; METABOLISM; PATHOLOGY; PHENOTYPE; THROMBOCYTE;

ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; BLOOD PLATELETS; CELL ADHESION; CELL ADHESION MOLECULES; ERYTHROCYTES; HUMANS; HYDROXYUREA; NEUTROPHILS; PHENOTYPE;

EID: 84908448427     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2014.108555     Document Type: Letter

References (15)

1. Hidalgo A, Chang J, Jang JE, Peired AJ, Chiang EY, Frenette PS. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med. 2009;15(4):384-91.
2. Turhan A, Jenab P, Bruhns P, Ravetch JV, Coller BS, Frenette PS. Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes. Blood. 2004; 103(6):2397-400.
3. Turhan A, Weiss LA, Mohandas N, Coller BS, Frenette PS. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm. Proc Natl Acad Sci USA. 2002;99(5):3047-51.
4. May AE, Langer H, Seizer P, Bigalke B, Lindemann S, Gawaz M. Platelet-leukocyte interactions in inflammation and atherothrombosis. Semin Thromb Hemost. 2007;33(2):123-7.
5. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest. 1995;25(11):843-51.
6. Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, Figler R, et al. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Art Thromb Vascular Biol. 2010;30(12):2392-9.
7. Brittain JE, Knoll CM, Ataga KI, Orringer EP, Parise LV. Fibronectin bridges monocytes and reticulocytes via integrin alpha4beta1. Br J Haematol. 2008;141(6):872-81.
8. Chaar V, Picot J, Renaud O, Bartolucci P, Nzouakou R, Bachir D, et al. Aggregation of mononuclear and red blood cells through an {alpha}4{beta}1-Lu/basal cell adhesion molecule interaction in sickle cell disease. Haematologica. 2010;95(11):1841-8.
9. Finnegan EM, Turhan A, Golan DE, Barabino GA. Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vasoocclusion. Am J Hematol. 2007;82(4):266-75.
10. Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med. 1997;129(5):507-16.
11. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69(1):11-25.
12. Novelli EM, Kato GJ, Ragni MV, Zhang Y, Hildesheim ME, Nouraie M, et al. Plasma thrombospondin-1 is increased during acute sickle cell vaso-occlusive events and associated with acute chest syndrome, hydroxyurea therapy, and lower hemolytic rates. Am J Hematol. 2012;87(3):326-30.
13. Proenca-Ferreira R, Brugnerotto AF, Garrido VT, Dominical VM, Vital DM, Ribeiro Mde F, et al. Endothelial activation by platelets from sickle cell anemia patients. PloS one. 2014;9(2):e89012.
14. Kutlar A, Ataga KI, McMahon L, Howard J, Galacteros F, Hagar W, et al. A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease. Am J Hematol. 2012;87(5):536-9.
15. Telen MJ Wun T, McCavit TL, De Castro LM, Krishnamurti L, Lanzkron S, et al. GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease. Blood. 2013;122(21):Abstract 7